(Q36290168)

English

'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus (English)

1 reference

Europe PubMed Central

13 August 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

0 references

1

1 reference

Europe PubMed Central

13 August 2017

publication date

18 October 2005

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

44

1 reference

Europe PubMed Central

13 August 2017

12

1 reference

Europe PubMed Central

13 August 2017

1492-1502

1 reference

Europe PubMed Central

13 August 2017

The bimodal mortality pattern of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Women and heart disease: the role of diabetes and hyperglycemia

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Risk factors for cardiovascular disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Is atherosclerosis an immunologically mediated disease?

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Innate and adaptive immunity in the pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

The atherogenic effect of lupus sera: Systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Regulation of immune responses by TGF-beta

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Cardiovascular risk in systemic lupus erythematosus--evidence of increased oxidative stress and dyslipidaemia

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Factors associated with coronary artery calcification in young female patients with SLE.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Vasculopathy of the antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Hyperlipidemia and thrombotic complications in patients with membranous nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Insulin resistance and vascular function

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Clinical and experimental evaluation of the thromboprophylactic effect of hydroxychloroquine sulfate after total hip replacement

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Prevention of the platelet alpha-granule release reaction by membrane-active drugs

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Chloroquine extends the lifetime of the activated insulin receptor complex in endosomes

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI142

21 January 2018

Identifiers

10.1093/RHEUMATOLOGY/KEI142

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36290168&oldid=1623672411"